Solid Corp (SLDB): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Solid Biosciences Inc. (SLDB) aniq gen yetkazib berish uchun maxsus kapsidlarni ishlab chiqish orqali Dyushenn mushak distrofiyasi terapiyasiga e'tibor qaratadi. Biznes modeli ishlab chiqarish zavodlarining xarajatlarisiz, patentlar orqali miqyosni kengaytirish potentsialiga tayanadi, garchi kompaniya hozirda mablag'larni tadqiqotlarga sarflayotgan bo'lsa-da. Tijoratlashtirilgan mahsulotlarning yo'qligi uning tor ixtisoslashuvi tufayli yuqori xatarlarni yuzaga keltiradi. Ushbu grafik 0.05 metrik qiymatidagi bozor narxiga asoslangan kompaniyaning uzoq muddatli qarzdorligini aks ettiradi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_SLDB_-_Solid-Biosciences-Inc._-_Long-Term-Debt-to-Capital "SLDB: Solid Biosciences Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 | 👁️GURU.Markets👁️")
Solid Biosciences Inc. kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Solid Biosciences Inc.|SLDB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati solidbio.com|SLDB - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Solid Biosciences Inc.|SLDB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzdorligi Solid Biosciences
Fundamental baholash:SLDB, Solid Biosciences Inc
Solid Biosciences Inc. (SLDB) uchun, uning baholanishi gen terapiyasi xavfsizligiga bo'lgan ishonchga asoslangan bo'lib, ushbu ko'rsatkich uzoq muddatli rivojlanishning qarz kapitaliga bog'liqligini belgilaydi. Uzoq muddatli qarzlarning kapitalga nisbati tahlili orqali investor bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbatan ulushini baholaydi, bu esa biznes transformatsiyasi davrida strategik investitsiyalarni kritik to'lovga qobiliyatsizlik xavfidan farqlash imkonini beradi.
Solid Biosciences Inc. raqobatchilari
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group QGEN|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Isis Pharmaceuticals (IONS)|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|aviditybiosciences.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CRSP (CRISPR Therapeutics)|WGS: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati RARE|BEAM (Beam Tx) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Sarepta Therapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati twistbioscience.com|TXG (10x Genomics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Intellia Therapeutics Inc (NTLA)|STOK - Uzoq muddatli qarzning kapitalga nisbati|BLFS - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Wave Life Sciences (WVE)|MAZE - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Sionna Therapeutics (SION) - Uzoq muddatli qarzning kapitalga nisbati|Prime Medicine Inc (PRME) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TSHA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati QURE|MeiraGTx Holdings plc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati RGNX (regenxbio.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati OCGN|Uzoq muddatli qarzdorlikning kapitalga nisbati Pacific Biosciences of California, Inc. PACB|BNTC: Uzoq muddatli qarzning kapitalga nisbati|DSGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Rocket Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati|4dmoleculartherapeutics.com (FDMT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati LXEO (Lexeo Therapeutics Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati KRRO|Uzoq muddatli qarzning o'z kapitaliga nisbati Editas EDIT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Silence Therapeutics Corp (SLN)|ProQR Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Codexis Inc CDXS|SGMO (Sangamo Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|NAUT: Uzoq muddatli majburiyatlarning kapitalga nisbati|Metagenomi, Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Precision BioSciences Inc.|GBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti boundlessbio.com|XCUR (Exicure, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati IMNN (imunon.com)|PHIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Mustang Bio Inc MBIO|RNAZ: Uzoq muddatli qarzning kapitalga nisbati|Bionano Genomics, Inc. (BNGO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Applied DNA Sciences, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|BLUE (bluebird bio Inc.) - Uzoq muddatli qarzdorlikning kapitalga nisbati|IPA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati OMGA|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|Uzoq muddatli qarzning o'z kapitaliga nisbati regulusrx.com (RGLS)|SYRS - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Telesis Bio Inc. TBIO|TCON - Uzoq muddatli qarzning kapitalga nisbati|UBX - Uzoq muddatli qarzning o'z kapitaliga nisbati